Skip to main content
Premium Trial:

Request an Annual Quote

LGC to Distribute NuGen Target Enrichment Technology

NEW YORK (GenomeWeb) – Life science company LGC has signed an agreement to offer NuGen's single-primer enrichment technology (SPET) for next-generation sequencing target enrichment, the companies announced today.

SPET is designed for the targeted sequencing of both DNA and RNA, and enables applications such as the detection of germline and somatic aberrations for molecular diagnostics and targeted genotyping for animal and plant breeding, according to NuGen.

Under the terms of the deal, LGC will offer the technology through its recently launched SeqSNP targeted genotyping service for animal and plant breeding. It will also distribute NuGen's SPET-based Allegro Targeted Genotyping kits — which are used for targeted genotyping-by-sequencing on a variety of organisms via NGS — for use in local laboratories.

Additional terms were not disclosed.

"We developed Allegro as a tool for high-throughput, large-scale targeted genotyping, and the agrigenomics market is a perfect fit," NuGen CEO Nitin Sood said in a statement. "We are excited to have an experienced partner like LGC making Allegro Targeted Genotyping available to a broader audience."